Chronic urticaria: Difference between revisions

No edit summary
 
Line 28: Line 28:


==Management==
==Management==
*H1/H2 blockers
*[[antihistamines|H1/H2 blockers]]
**[[Diphenhydramine]]
**[[Diphenhydramine]]
**[[Famotidine]]
**[[Famotidine]]
*2nd line agents: TCAs
*2nd line agents: antidepressants
**[[Doxepin]] <ref> Simons FE, et al; Histamine and H1-antihistamines: celebrating a century of progress. PMID: 22035879 </ref>
**[[Doxepin]] <ref> Simons FE, et al; Histamine and H1-antihistamines: celebrating a century of progress. PMID: 22035879 </ref>
***Start at 10 mg daily and increase to 10 mg TID <ref> Yadav, S, et al; Management of difficult urticaria. PMID: 20161863 </ref>
***Start at 10 mg daily and increase to 10 mg TID <ref> Yadav, S, et al; Management of difficult urticaria. PMID: 20161863 </ref>
Line 38: Line 38:
**[[Mirtazapine]]
**[[Mirtazapine]]
***15 mg daily <ref> Bigatà X, et al; Severe chronic urticaria: response to mirtazapine. PMID: 16243165 </ref>
***15 mg daily <ref> Bigatà X, et al; Severe chronic urticaria: response to mirtazapine. PMID: 16243165 </ref>
*Consider corticosteroids
*Consider [[corticosteroids]]
**[[methylprednisolone]] 125mg IV/IM OR [[prednisone]] 60mg PO
**[[methylprednisolone]] 125mg IV/IM OR [[prednisone]] 60mg PO



Latest revision as of 20:39, 27 September 2019

Background

  • Recurrent urticaria at least twice per week for 6 weeks [1]
  • Often autoimmune etiology

Types

Clinical Features

Raised urticaria

Differential Diagnosis

Acute allergic reaction

Evaluation

Management

Disposition

  • Discharge if no concern for anaphylaxis

See Also

External Links

References

  1. Grattan, et al, Chronic urticaria; PMID: 22345759
  2. Sachdeva, S, et al; Chronic Urticaria; PMID: 22345759
  3. Simons FE, et al; Histamine and H1-antihistamines: celebrating a century of progress. PMID: 22035879
  4. Yadav, S, et al; Management of difficult urticaria. PMID: 20161863
  5. Bigatà X, et al; Severe chronic urticaria: response to mirtazapine. PMID: 16243165